Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models.
Saved in:
| Title: | Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models. |
|---|---|
| Authors: | Kuo, Chun-Ting1, Chen, Chen-Lin1, Li, Chih-Chi1, Huang, Guan-Syuan1, Ma, Wei-Yuan1, Hsu, Wei-Fan1, Lin, Ching-Hung2, Lu, Yen-Shen2 yslu@ntu.edu.tw, Wo, Andrew M.1 andrew@iam.ntu.edu.tw |
| Source: | Scientific Reports. 8/20/2020, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 145201272 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kuo%2C+Chun-Ting%22">Kuo, Chun-Ting</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Chen%2C+Chen-Lin%22">Chen, Chen-Lin</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Li%2C+Chih-Chi%22">Li, Chih-Chi</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Huang%2C+Guan-Syuan%22">Huang, Guan-Syuan</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Ma%2C+Wei-Yuan%22">Ma, Wei-Yuan</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hsu%2C+Wei-Fan%22">Hsu, Wei-Fan</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Lin%2C+Ching-Hung%22">Lin, Ching-Hung</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Lu%2C+Yen-Shen%22">Lu, Yen-Shen</searchLink><relatesTo>2</relatesTo><i> yslu@ntu.edu.tw</i><br /><searchLink fieldCode="AR" term="%22Wo%2C+Andrew+M%2E%22">Wo, Andrew M.</searchLink><relatesTo>1</relatesTo><i> andrew@iam.ntu.edu.tw</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Scientific+Reports%22">Scientific Reports</searchLink>. 8/20/2020, pN.PAG-N.PAG. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=145201272 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-020-68553-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kuo, Chun-Ting – PersonEntity: Name: NameFull: Chen, Chen-Lin – PersonEntity: Name: NameFull: Li, Chih-Chi – PersonEntity: Name: NameFull: Huang, Guan-Syuan – PersonEntity: Name: NameFull: Ma, Wei-Yuan – PersonEntity: Name: NameFull: Hsu, Wei-Fan – PersonEntity: Name: NameFull: Lin, Ching-Hung – PersonEntity: Name: NameFull: Lu, Yen-Shen – PersonEntity: Name: NameFull: Wo, Andrew M. IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 08 Text: 8/20/2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 20452322 Titles: – TitleFull: Scientific Reports Type: main |
| ResultId | 1 |